Cementoblast gene expression is regulated by Porphyromonas gingivalis Lipopolysaccharide partially via toll-like receptor-4/MD-2

Journal of Dental Research

Volumn 83, Issue 8, 2004, Pages 602-607

  Nociti Jr , F H ^a,b   Foster, B L ^b   Barros, S P ^a   Darveau, R P ^b   Somerman, M J ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cementoblasts; Cytokines; Lipopolysaccharides; Porphyromonas gingivalis

Indexed keywords

CARRIER PROTEIN; CD14 ANTIGEN; CELL RECEPTOR; CELL SURFACE RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LY ANTIGEN; LY96 PROTEIN, MOUSE; MEMBRANE PROTEIN; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; PROTEIN MD 2; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SIALOGLYCOPROTEIN; SPP1 PROTEIN, MOUSE; TNFRSF11A PROTEIN, MOUSE; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; CELL CULTURE; CEMENTUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NORTHERN BLOTTING; OSTEOCLAST; PORPHYROMONAS GINGIVALIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTIGENS, CD14; ANTIGENS, LY; BLOTTING, NORTHERN; CARRIER PROTEINS; CELLS, CULTURED; DENTAL CEMENTUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLYCOPROTEINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; NF-KAPPA B; OSTEOCALCIN; OSTEOCLASTS; OSTEOPONTIN; OSTEOPROTEGERIN; PORPHYROMONAS GINGIVALIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 4444334723     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910408300804     Document Type: Article

References (30)

1. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M, et al. (2000). Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164:3471-3475.
2. Bainbridge BW, Coats SR, Darveau RP (2002). Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system. Ann Periodontol 7:29-37.
3. Chiang CY, Kyritsis G, Graves DT, Amar S (1999). Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67:4231-4236.
4. Choi BK, Lee HJ, Kang JH, Jeong GJ, Min CK, Yoo YJ (2003). Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. Infect Immun 71:226-233.
5. Coats SR, Reife RA, Bainbridge BW, Pham TT, Darveau RP (2003). Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect Immun 71:6799-6807.
6. D'Errico JA, Berry JE, Ouyang H, Strayhorn CL, Windle JJ, Somerman MJ (2000). Employing a transgenic animal model to obtain cementoblasts in vitro. J Periodontol 71:63-72.
7. Darveau RP, Arbabi S, Garcia I, Bainbridge B, Maier RV (2002). Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect Immun 70:1867-1873.
8. Denhardt DT, Giachelli CM, Rittling SR (2001). Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41:723-749.
9. Grzesik WJ, Kuzentsov SA, Uzawa K, Mankani M, Robey PG, Yamauchi M (1998). Normal human cementum-derived cells: isolation, clonal expansion, and in vitro and in vivo characterization. J Bone Miner Res 13:1547-1554.
10. Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF (2002). Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 70:3143-3148.
11. Jin CH, Miyaura C, Ishimi Y, Hong MH, Sato T, Abe E, et al. (1990). Interleukin 1 regulates the expression of osteopontin mRNA by osteoblasts. Mol Cell Endocrinol 74:221-228.
12. Kadono H, Kido J-I, Kataoka M, Yamauchi N, Nagata T (1999). Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 67:2841-2846.
13. Katagiri T, Takahashi N (2002). Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8:147-159.
14. Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, et al. (2001). Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via toll-like receptors. J Immunol 166:3574-3579.
15. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
16. Locklin RM, Khosla S, Turner RT, Riggs BL (2003). Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89:180-190.
17. Loomer PM, Sigush B, Sukhu B, Ellen RP, Tenenbaum HC (1994). Direct effects of metabolic products and sonicated extracts of Porphyromonas gingivalis 2561 on osteogenesis in vitro. Infect Immun 62:1289-1297.
18. Murata T, Ansai T, Takehara T, Kobayashi S, Haneji T (1997). Extracts of Prevotella intermedia and Actinobacillus actinomycetemcomitans inhibit alkaline phosphatase activity in osteoblastic cells in vitro. Oral Dis 3:106-112.
19. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, et al. (2002). Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667-672.
20. Nagasawa T, Kobayashi H, Kiji M, Aramaki M, Mahanonda R, Kojima T, et al. (2002). LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 130:338-344.
21. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B (1996). Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 64:2371-2380.
22. Ouyang H, Franceschi RT, McCauley LK, Wang D, Somerman MJ (2000). Parathyroid hormone-related protein down-regulates bone sialoprotein gene expression in cementoblasts: role of the protein kinase A pathway. Endocrinology 141:4671-4680.
23. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
24. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
25. Suda K, Woo JT, Takami M, Sexton PM, Nagai K (2002). Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol 190:101-108.
26. Tsukahara Y, Lian Z, Zhang X, Whitney C, Kluger Y, Tuck D, et al. (2003). Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharide. J Cell Biochem 89:848-861.
27. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
28. Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ (2002). Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res 17:1441-1451.
29. Zhao M, Berry JE, Somerman MJ (2003). Bone morphogenetic protein-2 inhibits differentiation and mineralization of cementoblasts in vitro. J Dent Res 82:23-27.
30. Zou W, Bar-Shavit Z (2002). Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17:1211-1218.